Quartz

It’s now worth more than $1.5 billion. Shares in GW Pharmaceuticals, a very modern business based in the ancient English city of Salisbury, have soared by 15% today. Why? Further signs the company’s cannabinoid-based treatment for epilepsy might actually work. The company announced this morning…